Department of Dermatology, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
J R Coll Physicians Edinb. 2022 Dec;52(4):287-291. doi: 10.1177/14782715221132858. Epub 2022 Oct 25.
Proton pump inhibitors (PPIs) are extensively prescribed but may cause photosensitivity and drug-induced lupus erythematosus (DILE), which can be overlooked as the drug may have been taken for years prior to presentation.
We reviewed the clinical and investigation findings of patients diagnosed with PPI-induced photosensitivity, diagnosed through the Scottish Photobiology Service.
We report 11 patients with median age of onset 61-years and mean duration of PPI ingestion of 5-years [DILE ( = 6), phototoxicity ( = 3) and drug-induced solar urticaria through a lupus mechanism ( = 2)]. Five had Anti-Ro antibodies (three also ANA positive). Predominantly UVA and visible light photosensitivity was observed on phototesting.
PPIs are a reversible cause of photosensitivity and DILE. Time to onset from drug initiation to symptoms can be prolonged, so clinicians should have a high index of suspicion in those taking PPIs. Most are diagnosed through clinical assessment and lupus serology, with phototesting indicated if there is diagnostic uncertainty.
质子泵抑制剂 (PPIs) 被广泛应用,但可能引起光过敏和药物诱导的狼疮 (DILE),由于药物在出现症状之前可能已经服用多年,因此可能被忽视。
我们回顾了在苏格兰光生物学服务中心诊断为 PPI 诱导的光过敏的患者的临床和检查结果。
我们报告了 11 名患者,发病年龄中位数为 61 岁,PPI 服用时间平均为 5 年[DILE(=6)、光毒性(=3)和通过狼疮机制引起的药物诱导性日光性荨麻疹(=2)]。其中 5 人抗 Ro 抗体阳性(其中 3 人抗核抗体阳性)。光过敏试验观察到主要是 UVA 和可见光光敏性。
PPIs 是光过敏和 DILE 的一个可逆转的原因。从药物开始到出现症状的时间可能会延长,因此临床医生应该对服用 PPI 的患者保持高度警惕。大多数通过临床评估和狼疮血清学诊断,如果存在诊断不确定性,则需要进行光过敏试验。